Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2023
New Titles 2022
Price and Ordering Information
Subscription Rates 2022
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Advertising Policy
Journals and eBooks Catalog
Media-Pack-2022
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
Fabricating and Stating False Information
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Short Guide
Journal Catalog 2021
Journal Catalog 2022
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Research Misconduct
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Current Medicinal Chemistry - Anti-Cancer Agents
Continued as:
Anti-Cancer Agents in Medicinal Chemistry
Volume 5, 6 Issues, 2005
ISSN: 1875-5968 (Online)
ISSN: 1568-0118 (Print)
This journal supports open access
Contents
Current Medicinal Chemistry - Anti-Cancer Agents
,
Volume 4
- Number 5
Preface [Hot Topic: Special Editorial Board Issue (Guest Editor: Christian Bailly)]
,
4
(
5
):
i
Christian Bailly
DOI:
10.2174/1568011043352759
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Antitumor Pharmacology - Quo Vadis ?
,
4
(
5
):
389
- 391
Christian Bailly, Jean-Marc Barret and Anna Kruczynski
DOI:
10.2174/1568011043352849
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
A Rational Selection of Drug Targets Needs Deeper Insights into General Regulation Mechanisms
,
4
(
5
):
393
- 394
Giovanni Capranico
DOI:
10.2174/1568011043352821
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Prospects for Hypoxia-Activated Anticancer Drugs
,
4
(
5
):
395
- 399
William A. Denny
DOI:
10.2174/1568011043352812
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Modelling and Simulation: A Computational Perspective in Anticancer Drug Discovery
,
4
(
5
):
401
- 403
Federico Gago
DOI:
10.2174/1568011043352786
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Antifolates - Past, Present and Future
,
4
(
5
):
405
- 410
Aleem Gangjee and Hiteshkumar D. Jain
DOI:
10.2174/1568011043352803
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Monoclonal Antibodies in Cancer Therapy
,
4
(
5
):
411
- 414
Barbara Gatto
DOI:
10.2174/1568011043352713
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Amplification of Anticancer Drug-Induced DNA Damage and Apoptosis by DNA-Binding Compounds
,
4
(
5
):
415
- 419
Shosuke Kawanishi and Yusuke Hiraku
DOI:
10.2174/1568011043352867
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Novel Molecular Targets in Cancer Chemotherapy Waiting for Discovery
,
4
(
5
):
421
- 423
Conrad Kunick
DOI:
10.2174/1568011043352858
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Anticancer Agents: Towards the Future
,
4
(
5
):
425
- 427
Manlio Palumbo
DOI:
10.2174/1568011043352731
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Camptothecins and Topoisomerase I; A Foot in the Door. Targeting the Genome Beyond Topoisomerase I with Camptothecins and Novel Anticancer Drugs; Importance of DNA Replication, Repair and Cell Cycle Checkpoints
,
4
(
5
):
429
- 434
Yves Pommier
DOI:
10.2174/1568011043352777
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Combining DNA Damaging Agents and Checkpoint 1 Inhibitors
,
4
(
5
):
435
- 438
Michelle Prudhomme
DOI:
10.2174/1568011043352795
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase Inhibitors
,
4
(
5
):
439
- 443
Jean-Francois Riou
DOI:
10.2174/1568011043352740
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
,
4
(
5
):
445
- 447
Edward A. Sausville
DOI:
10.2174/1568011043352876
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
,
4
(
5
):
449
- 455
Tomi K. Sawyer
DOI:
10.2174/1568011043352830
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Resistance in Cancer: A Target for Drug Discovery
,
4
(
5
):
457
- 460
Mark Searcey and Laurence H. Patterson
DOI:
10.2174/1568011043352722
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis
,
4
(
5
):
461
- 463
Francois Martin and Eric Solary
DOI:
10.2174/1568011043352768
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
About the Journal
⇨ Journal Home
For Librarians & Readers
⇨ Contents & Abstracts
Quick Links
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2022 Bentham Science
|
Privacy Policy